
Neurotechnologies – status quo and development potential
- Project team:
- Thematic area:
- Topic initiative:
Committee on Research, Technology, Space and Technology Assessment
- Analytical approach:
TA-Kompakt
- Startdate:
December 2025
- Enddate:
2026
In a nutshell
Neurotechnologies enable the measurement, analysis and modulation of neural activity. The field is developing rapidly and opening up new applications in medicine, everyday life and the military. At the same time, new questions are emerging regarding privacy, autonomy, security and regulation.
This TA-Kompakt study analyses the the status quo and future prospects of invasive and non-invasive neurotechnologies, examines their applications, and assesses the associated ethical, legal and societal challenges. It also explores the dynamics of international competition, identifies areas where Germany may need to take action, and discusses approaches to responsible governance.
The key findings are summarised below in eight questions and answers.
- In the field of invasive neurotechnologies, the focus is on miniaturising implants, achieving significantly higher electrode densities, transmitting data wirelessly and using new biocompatible materials. The aim is to improve signal quality, usability in real-world settings and, ultimately, long-term stability.
- In the case of non-invasive methods, dry electrodes in particular have made them easier to use outside of laboratories. Furthermore, techniques such as transcranial temporal interference stimulation (tTIS) and focused ultrasound (fUS) are being tested to specifically stimulate deeper brain regions.
- A key driver of development in both areas is AI. AI improves the decoding of neural signals and enables adaptive closed-loop systems that adjust stimulation in real time in response to measured brain activity.
- Neurotechnologies are primarily used to treat severe cases of Parkinson's disease, epilepsy, chronic pain and, to a certain extent, depression. Stimulation techniques are the main method of treatment. Current development efforts focus on adaptive closed-loop systems, which aim to personalise and improve the efficiency of therapies.
- Non-invasive brain-computer interfaces (BCIs) are most advanced in the form of communication aids for patients with ALS and locked-in syndrome, such as spelling aids and cursor control, as well as in stroke rehabilitation.
- Invasive interfaces are required for precise mental control of prostheses and exoskeletons, as well as for decoding intended speech. The number of clinical trials is increasing, and initial successes in individual cases demonstrate the fundamental feasibility of this technology. Nevertheless, development remains largely at the pilot and proof-of-concept stage, with only small numbers of patients involved.
- The consumer market for neurotechnologies has grown significantly in recent years. The focus is on wellness and fitness applications, with wearable EEG systems increasingly enabling their use in everyday settings.
- Furthermore, neurotechnologies are being trialled for gaming and XR applications, as well as for monitoring attention, fatigue, and learning processes in the workplace and educational settings. However, scientific evidence of their benefits is often limited.
- In the military sector, neurotechnologies have been developed for decades, primarily by the USA and increasingly by China. Current efforts focus on rehabilitation, human-machine teaming, and performance enhancement. Their dual-use nature makes this a field of technology relevant to security policy, in which international competition for technological leadership is emerging.
- Neurotechnological approaches to enhancing the performance of healthy individuals remain largely experimental. Due to the associated risks, invasive approaches are still considered impractical for widespread use.
- The focus is therefore on non-invasive stimulation methods, such as transcranial direct current stimulation. While some studies have shown short-term improvements in learning or attentional performance, the findings are inconsistent and their applicability to everyday life and the workplace remains unclear.
- The development of medical neurotechnologies is hindered by stringent regulatory requirements, lengthy development times, and high costs. With invasive procedures in particular, there is often a ‘valley of death’ between research success and market launch.
- For non-medical applications, the regulatory hurdles are lower. Here, a lack of evidence of benefit, limited user acceptance and uncertain business models pose the greatest challenges.
- A fundamental technical challenge is the trade-off between signal quality and invasiveness. Invasive systems provide the most precise signals but require surgical intervention and are associated with long-term risks. Non-invasive systems are significantly safer and more suitable for everyday use, but they offer lower spatial resolution and data quality. Advances in materials, sensor technology and AI can reduce this trade-off, but are unlikely to eliminate it entirely.
- Germany is among the world's leading countries in neuroscience research. It also benefits from a strong health research sector, excellent university medical centres and a competitive medical technology industry.
- However, this strength is only partially translated into start-ups, clinical translation and commercial applications. Germany lags significantly behind the leading centres, particularly the USA, when it comes to funding, scaling, and commercialisation of neurotechnologies.
- A key problem is the growing regulatory grey area between medical devices and consumer applications. Many neurotechnologies are marketed as wellness or lifestyle products despite advertising health-related benefits. Consequently, they often face significantly lower regulatory and evidence requirements than comparable medical applications.
- As the ability to measure and influence neural activity increases, issues relating to the protection of mental privacy, freedom of thought, and personal autonomy are becoming increasingly important. There is an ongoing debate about the legal protection of neural data and the limits that should apply to interventions in neural processes.
- Added to this are questions of fairness. The focus is on ensuring fair access to neurotechnological applications, preventing new social inequalities and promoting needs-based innovation, with the involvement of patients and particularly vulnerable groups.
- UNESCO’s Recommendations on the Ethics of Neurotechnologies now provide an internationally supported framework for addressing these challenges, which must now be further refined and implemented.
Given their potential significance for health policy, industrial innovation and national security, neurotechnologies could increasingly be regarded as a strategic field of technology. Possible policy options include a national strategy, continuous technology monitoring and clearly defined funding priorities.
Key levers include strengthening existing innovation clusters, promoting clinical translation and creating better conditions for the establishment and growth of neurotechnology start-ups. Alongside this, more efficient regulatory procedures can help accelerate innovation without compromising safety standards.
Responsible development also requires the early involvement of user groups, testing new governance instruments such as regulatory sandboxes and other experimental governance approaches, and greater engagement in developing and establishing international standards and norms.
Methodological Approach
The TA-Kompakt is based on an analysis of scientific and grey literature, as well as discussions with experts from various disciplines. These discussions served to identify relevant topics and developments, as well as to contextualise and validate the assessments presented in the report.
Download
![]() |
TA-Kompakt Nr. 8:
Die Reihe TA‑Kompakt bereitet aktuelle wissenschaftlich-technische Entwicklungen für den Deutschen Bundestag in konzentrierter Form auf. Sie ergänzt die ausführlichen TAB-Berichte und unterstützt politische Entscheidungsprozesse durch eine kompakte und verständliche Darstellung zentraler Ergebnisse. |
In the Bundestag
The final report of the TA project was approved by the Committee on Research, Technology, Space and Technology Assessment on 3 November 2026 and is thus feeding into parliamentary deliberations.
Case – Report on the Parliamentary Server (DIP, in German only)
Technology Assessment (TA)
Neurotechnologies – status quo and development potential
Earlier publications on the topic
Kehl, C.
2018, May. Büro für Technikfolgen-Abschätzung beim Deutschen Bundestag (TAB)
Kehl, C.
2018. Büro für Technikfolgen-Abschätzung beim Deutschen Bundestag (TAB). doi:10.5445/IR/1000094095
Kehl, C.; Coenen, C.
2016. Büro für Technikfolgen-Abschätzung beim Deutschen Bundestag (TAB). doi:10.5445/IR/1000063606
